Hepatic hemangioma natural history, complications and prognosis

Revision as of 14:56, 9 November 2015 by Nawal Muazam (talk | contribs)
Jump to navigation Jump to search

Hepatic hemangioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatic Hemangioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatic hemangioma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatic hemangioma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatic hemangioma natural history, complications and prognosis

CDC on Hepatic hemangioma natural history, complications and prognosis

Hepatic hemangioma natural history, complications and prognosis in the news

Blogs on Hepatic hemangioma natural history, complications and prognosis

Directions to Hospitals Treating Hepatic hemangioma

Risk calculators and risk factors for Hepatic hemangioma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Hepatic hemangioma natural history

  • Hepatic hemangioma is the most common benign liver tumor and typically remains stable in size.[1]
  • These are usually diagnosed as asymptomatic incidental findings.
  • Hemangiomas also (rarely) rupture spontaneously or by trauma and then lead to acute hemorrhagic shock with upper abdominal pain.[2][3]
  • In the worldwide literature a total of only 97 cases with a rupture of a hemangioma have been published, whereas a spontaneous rupture only happened in 47.4% of cases.[4][3]
  • Further investigation showed that these spontaneously ruptured hemangiomas had a mean size of 11.2 cm.[3][4]
  • Despite therapy, in these situations the mortality rate is 30-40%.[3]
  • Hemangiomas generally have no growth tendency. In the literature, however, cases of hemangioma growth during pregnancy or after estrogen administration are described [1, 10]. Hemangiomas (10 cm should generally not be treated, even before a pregnancy. In case of a planned pregnancy and a size )10 cm, due to the risk of a possible rupture, a definitive treatment should be discussed [1, 10]. Several studies have concluded that a spontaneous rupture of a hemangioma (even while pregnancy) [10, 19] occurs only very rarely, and therefore a prophylactic resection should only be conducted under special conditions and especially with a size of the hemangioma >11 cm [10]. In case of hemangiomas with high growth trend (>3 cm in 12 months), with symptomatic compression symptoms or recurrent pain, which may correlate with hemorrhage into the lesion, surgical intervention should be indicated [18, 19]. Because of hypotension, unexplained anemia, or diagnosis difficulties of the liver lesion, surgical intervention can be rarely necessary.[3]

Complications

In rare cases, a cavernous hemangioma may rupture. Babies may develop a type of hepatic hemangioma called benign infantile hemangioendothelioma (also called multinodular hepatic hemangiomatosis). This rare, noncancerous tumor has been linked to high rates of heart failure and death in infants. Infants are usually diagnosed by the time they are 6 months old. Pregnancy and estrogen-based medications can cause cavernous hemangiomas to grow.

Prognosis

References

  1. Maruyama, Masaki; Isokawa, Osamu; Hoshiyama, Koki; Hoshiyama, Ayako; Hoshiyama, Mari; Hoshiyama, Yoshihiro (2013). "Diagnosis and Management of Giant Hepatic Hemangioma: The Usefulness of Contrast-Enhanced Ultrasonography". International Journal of Hepatology. 2013: 1–6. doi:10.1155/2013/802180. ISSN 2090-3448.
  2. Assy, Nimer (2009). "Characteristics of common solid liver lesions and recommendations for diagnostic workup". World Journal of Gastroenterology. 15 (26): 3217. doi:10.3748/wjg.15.3217. ISSN 1007-9327.
  3. 3.0 3.1 3.2 3.3 3.4 Ehrl, Denis; Rothaug, Katharina; Herzog, Peter; Hofer, Bernhard; Rau, Horst-Günter (2012). ""Incidentaloma" of the Liver: Management of a Diagnostic and Therapeutic Dilemma". HPB Surgery. 2012: 1–14. doi:10.1155/2012/891787. ISSN 0894-8569.
  4. 4.0 4.1 Donati, Marcello; Stavrou, Gregor A.; Donati, Angelo; Oldhafer, Karl J. (2011). "The risk of spontaneous rupture of liver hemangiomas: a critical review of the literature". Journal of Hepato-Biliary-Pancreatic Sciences. 18 (6): 797–805. doi:10.1007/s00534-011-0420-7. ISSN 1868-6974.